KRTL BioTech

Exor expects $13 billion for careful acquisitions after PartnerRe sale

Exor expects $13 billion for careful acquisitions after PartnerRe sale

Investment group Exor will have around $13 billion in cash provided it closes a deal to sell its reinsurance unit PartnerRe and it would spend most of that on acquisitions, a source close to the matter told Reuters.